Funding and collateral: the implication
Confirm the destination chain, account and usable margin. Funding a wallet does not necessarily fund the trading account or preserve the deposited asset.
DN Decision Briefs / Evidence comparison
ApeX Omni vs EVEDEX vs SAI
Compare funding paths, fee bases and exit conditions across three different perpetual systems. Gasless trading, signed fee caps and rewards are not interchangeable cost measures.
What Matters
Compare like with like. Keep the gaps visible.
3 pinned documentation briefs compared by decision condition. Not a live execution test, security audit, exhaustive product inventory or individual eligibility assessment.
ApeX Omni account transfers, EVEDEX USDT settlement and SAI collateral on Nibiru EVM describe distinct systems. This is a comparison of documented decision conditions, not a common-network test or an equal-depth product inventory.
DN Evidence Block
The conditions side by side.
| Decision factor | ApeX Omni | EVEDEX | SAI |
|---|---|---|---|
| Funding and collateral | The API guide separates the Omni funding account from the Perps account and describes a transfer between them. ApeX Omni API reference | The supported-currencies guide states that trades settle in USDT and that order-size and margin requirements vary by instrument. EVEDEX supported currencies | The About guide describes USDC and stNIBI collateral and bridge routes to Nibiru EVM. SAI platform and collateral guide |
| What a fee statement means | The FAQ defines Limit Fee as the maximum trading fee accepted in the signed request. It is an authorization bound. ApeX Omni API FAQ | The fee guide distinguishes liquidity-adding maker orders from liquidity-taking orders and charges on execution rather than mere order placement. EVEDEX trading fees | The fee guide distinguishes Nibiru gas from trading fees, automated-order trigger charges and bridging costs. SAI trading and rapid-close fees |
| Size and time sensitivity | This pinned snapshot does not establish a complete holding-cost model. | The leverage guide bases trading and funding costs on full position size, with trading fees applying to opening and closing. EVEDEX leverage and fees | The provider explanation describes a continuous borrowing fee updated by block rather than conventional fixed-window funding payments. SAI borrowing-model explanation |
| Exit conditions and incentives | The withdrawal-fee endpoint requires sufficient available balance; fast withdrawals also require available fast-pool liquidity. ApeX Omni API reference | The rewards guide describes benefit eligibility and a withdrawal example in which gas must also be covered. EVEDEX reward usage | The fee page describes an extra rapid-close charge that decays with holding time. Protected markets can use different peak settings. SAI trading and rapid-close fees |
| Execution evidence | The FAQ requires a signed price for market orders and describes conditions under which the order is cancelled. ApeX Omni API FAQ | This review does not establish personal eligibility, current executable depth, stop-loss reliability or withdrawal completion. | The Nibiru overview describes oracle settlement, market/limit orders and stop-loss/take-profit triggers. Nibiru SAI overview |
| Permissions and remaining risk | The FAQ distinguishes API credentials from zkLink signing keys. Order creation and withdrawal requests require zkLink signatures. ApeX Omni API FAQ | The onboarding guide offers external-wallet connection or an email-created wallet and describes recovery credentials for the latter. EVEDEX onboarding | The guide applies fee multipliers to ordinary trading charges but describes liquidation fees separately as collateral-based and exempt from those discounts. SAI trading and rapid-close fees |
| What remains unmeasured | This pinned snapshot provides no independent measurements of execution, withdrawal reliability or individual eligibility. | This pinned snapshot provides no independent measurements of execution, withdrawal reliability or individual eligibility. | This pinned snapshot provides no independent measurements of execution, withdrawal reliability or individual eligibility. |
What a fee statement means: the implication
A signed fee ceiling, maker/taker commission and gasless execution describe different things. Include trading, holding and exit costs before comparing totals.
Size and time sensitivity: the implication
Use full position size and the intended holding period. The ApeX snapshot does not establish a complete holding-cost model; missing evidence is not zero cost.
Exit conditions and incentives: the implication
Available withdrawal liquidity, reward eligibility and rapid-close fees affect different parts of an exit. They cannot be reduced to one payout or speed score.
Execution evidence: the implication
Order submission and supported order types do not prove fills or stop-loss reliability. No matched execution test is available.
Permissions and remaining risk: the implication
Signing keys, wallet recovery and liquidation penalties are different risk controls. DN has not audited their implementation or verified live revocation and recovery behaviour.
What remains unmeasured: the implication
Individual eligibility, current depth, all-in executable costs and independently tested withdrawals remain unknown. Documentation volume is not a safety ranking.
Evidence boundary
No invented rates. No implied guarantees.
- Matched executable quotes including entry, holding and exit costs
- Independent fill, stop-loss and withdrawal reliability
- Current permissions, recovery and revocation behaviour
- Individual eligibility and current regional restrictions
No numerical all-in cost is calculated. A valid comparison needs contemporaneous quotes for matching assets, product modes, notional sizes, directions and holding periods, with entry, holding and exit costs included.
Your research record
Keep the evidence.
Keep its limits.
The receipt preserves all underlying evidence snapshots and the comparison at version 1.0.0.
It is not a recommendation, approval, live quote or alert subscription. No account, balance, wallet or country is requested.
- Scope
- Perpetual trading across distinct product scopes
- Collateral scope
- Market, account and route dependent. No universal collateral equivalence or shared deployment is asserted.
- Evidence version
- 1.0.0 / 2026-10-14
- Live tested
- No
Change record
Reviewed dates, not inferred launch dates.
DN publication
Initial comparison of pinned documentation snapshots. Evidence coverage differs; unsupported conditions remain unknown.
Review triggers: Changed official product, fee, margin or withdrawal documentation; A substantiated correction; The earliest underlying editorial review deadline. No automated provider surveillance runs for this brief.
How to use this research
Provider-reported describes the source of a statement, not an independent endorsement. Unknown and not measured identify evidence gaps. A documentation review does not confer an operational-status classification or establish user eligibility.
DN may receive compensation through commercial links elsewhere on the site. This comparison has no trading CTA or payout-based ranking. Documentation does not establish current operational status, safety or user eligibility.
Educational research only, not investment, legal or tax advice. Leveraged derivatives can cause substantial losses.